Ledyard National Bank Bristol Myers Squibb CO Transaction History

Ledyard National Bank

  • $1.09 Billion
  • Q3 2024

A detailed history of Ledyard National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ledyard National Bank holds 25,218 shares of BMY stock, worth $1.47 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
25,218
Previous 25,803 2.27%
Holding current value
$1.47 Million
Previous $1.07 Million 21.85%
% of portfolio
0.12%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$39.66 - $51.75 $23,201 - $30,273
-585 Reduced 2.27%
25,218 $1.31 Million
Q2 2024

Aug 05, 2024
SELL
$40.25 - $52.99 $94,386 - $124,261
-2,345 Reduced 8.33%
25,803 $1.07 Million
Q1 2024

May 08, 2024
SELL
$47.98 - $54.4 $145,619 - $165,104
-3,035 Reduced 9.73%
28,148 $1.53 Million
Q4 2023

Feb 05, 2024
BUY
$48.48 - $57.85 $19,052 - $22,735
393 Added 1.28%
31,183 $1.6 Million
Q3 2023

Nov 07, 2023
SELL
$57.89 - $64.73 $16,382 - $18,318
-283 Reduced 0.91%
30,790 $1.79 Million
Q2 2023

Aug 09, 2023
SELL
$63.71 - $70.74 $30,262 - $33,601
-475 Reduced 1.51%
31,073 $1.99 Million
Q1 2023

Apr 25, 2023
SELL
$65.71 - $74.53 $24,904 - $28,246
-379 Reduced 1.19%
31,548 $2.19 Million
Q4 2022

Feb 06, 2023
SELL
$68.48 - $81.09 $11,504 - $13,623
-168 Reduced 0.52%
31,927 $2.3 Million
Q3 2022

Oct 18, 2022
SELL
$0.13 - $76.84 $92 - $54,479
-709 Reduced 2.16%
32,095 $2.28 Million
Q2 2022

Jul 19, 2022
SELL
$72.62 - $79.98 $90,411 - $99,575
-1,245 Reduced 3.66%
32,804 $2.53 Million
Q1 2022

Apr 25, 2022
SELL
$61.48 - $73.72 $4,918 - $5,897
-80 Reduced 0.23%
34,049 $2.49 Million
Q4 2021

Jan 31, 2022
SELL
$53.63 - $62.52 $202,238 - $235,762
-3,771 Reduced 9.95%
34,129 $2.13 Million
Q3 2021

Oct 20, 2021
BUY
$59.17 - $69.31 $27,099 - $31,743
458 Added 1.22%
37,900 $2.24 Million
Q2 2021

Jul 27, 2021
BUY
$61.91 - $67.42 $13,001 - $14,158
210 Added 0.56%
37,442 $2.5 Million
Q1 2021

Apr 27, 2021
BUY
$59.34 - $66.74 $53,999 - $60,733
910 Added 2.51%
37,232 $2.35 Million
Q4 2020

Jan 25, 2021
BUY
$57.74 - $65.43 $61,493 - $69,682
1,065 Added 3.02%
36,322 $2.25 Million
Q3 2020

Oct 21, 2020
SELL
$57.43 - $63.64 $80,976 - $89,732
-1,410 Reduced 3.85%
35,257 $2.13 Million
Q2 2020

Jul 24, 2020
BUY
$54.82 - $64.09 $42,321 - $49,477
772 Added 2.15%
36,667 $2.16 Million
Q1 2020

Apr 24, 2020
BUY
$46.4 - $67.43 $442,656 - $643,282
9,540 Added 36.2%
35,895 $2 Million
Q4 2019

Jan 31, 2020
BUY
$49.21 - $64.19 $101,815 - $132,809
2,069 Added 8.52%
26,355 $1.69 Million
Q3 2019

Oct 23, 2019
SELL
$42.77 - $50.71 $17,065 - $20,233
-399 Reduced 1.62%
24,286 $1.23 Million
Q2 2019

Jul 26, 2019
SELL
$44.62 - $49.34 $25,924 - $28,666
-581 Reduced 2.3%
24,685 $1.12 Million
Q1 2019

Apr 12, 2019
SELL
$45.12 - $53.8 $3,113 - $3,712
-69 Reduced 0.27%
25,266 $1.21 Million
Q4 2018

Jan 29, 2019
SELL
$48.76 - $63.23 $93,082 - $120,706
-1,909 Reduced 7.01%
25,335 $1.32 Million
Q3 2018

Oct 24, 2018
SELL
$55.19 - $62.25 $12,748 - $14,379
-231 Reduced 0.84%
27,244 $1.69 Million
Q2 2018

Jul 11, 2018
SELL
$50.53 - $62.98 $39,362 - $49,061
-779 Reduced 2.76%
27,475 $1.52 Million
Q1 2018

Apr 16, 2018
SELL
$59.92 - $68.98 $44,580 - $51,321
-744 Reduced 2.57%
28,254 $1.79 Million
Q4 2017

Jan 30, 2018
SELL
$59.94 - $65.35 $62,097 - $67,702
-1,036 Reduced 3.45%
28,998 $1.78 Million
Q3 2017

Oct 10, 2017
BUY
$55.23 - $63.74 $1.66 Million - $1.91 Million
30,034
30,034 $1.91 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ledyard National Bank Portfolio

Follow Ledyard National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email